Showing results (1081-1090 of 1,519) with videos related to

Sort By:
Pageof 152
Familial Cancer|July 26, 2012
Two cases of nevoid basal cell carcinoma syndrome associated with meningioma caused by a PTCH1 or SUFU germline mutationChihiro Kijima, Toshiyuki Miyashita, Maiko Suzuki, et al.
Familial Cancer|February 1, 2015
Defective DNA mismatch repair activity is common in sebaceous neoplasms, and may be an ineffective approach to screen for Lynch syndromeAnu R Lamba, Angela Y Moore, Todd Moore, et al.
Familial Cancer|September 28, 2012
Catalysts to withdrawal from familial ovarian cancer screening for surgery and reactions to discontinued screening: a qualitative studyKate J Lifford, Alison Clements, Lindsay Fraser, et al.
Familial Cancer|July 5, 2012
Advanced duodenal disease in familial adenomatous polyposis: how frequently should patients be followed up after successful therapy?Damian C Balmforth, Robin K S Phillips, Susan K Clark
Familial Cancer|June 20, 2012
Outcomes of a systems-level intervention offering breast cancer risk assessments to low-income underserved womenDarren Mays, McKane E Sharff, Tiffani A DeMarco, et al.
Familial Cancer|June 22, 2012
Novel germline c-MET mutation in a family with hereditary papillary renal carcinomaKarin A W Wadt, Anne-Marie Gerdes, Thomas V O Hansen, et al.
Familial Cancer|February 2, 2010
"I have always believed I was at high risk..." The role of expectation in emotional responses to the receipt of an average, moderate or high cancer genetic risk assessment result: a thematic analysis of free-text questionnaire commentsJ Hilgart, C Phelps, P Bennett, et al.
Familial Cancer|May 12, 2023
Colonoscopy surveillance in Lynch syndrome is burdensome and frequently delayedElsa L S A van Liere, Imke L Jacobs, Evelien Dekker, et al.
Familial Cancer|April 29, 2023
Hematologic toxicities of chemotherapy in breast and ovarian cancer patients carrying BRCA1/BRCA2 germline pathogenic variants. A single center experience and review of the literatureKetty Hu-Heimgartner, Noémie Lang, Aurélie Ayme, et al.
Familial Cancer|January 15, 2014
The MUTYH hotspot mutations p.G396D and p.Y179C do not cause substantial genetic susceptibility to biliary cancerM Casper, M Acalovschi, F Lammert, et al.
Pageof 152